The DOI matches its Crossref record; 226 of the 231 references it cites were found in a registry or an index.
Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome
Abstract
The aetiology of polycystic ovary syndrome (PCOS) remains unknown. This familial syndrome is prevalent among reproductive-aged women and its inheritance indicates a dominant regulatory gene with incomplete penetrance. However, promising candidate genes have proven unreliable as markers for the PCOS phenotype. This lack of genetic linkage may represent both extreme heterogeneity of PCOS and difficulty in establishing a universally accepted PCOS diagnosis. Nevertheless, hyperandrogenism is one of the most consistently expressed PCOS traits. Animal models that mimic fetal androgen excess may thus provide unique insight into the origins of the PCOS syndrome. Many female mammals exposed to androgen excess in utero or during early post-natal life typically show masculinized and defeminized behaviour, ovulatory dysfunction and virilized genitalia, although behavioural and ovulatory dysfunction can coexist without virilized genitalia based upon the timing of androgen excess. One animal model shows particular relevance to PCOS: the prenatally androgenized female rhesus monkey. Females exposed to androgen excess early in gestation exhibit hyperandrogenism, oligomenorrhoea and enlarged, polyfollicular ovaries, in addition to LH hypersecretion, impaired embryo development, insulin resistance accompanying abdominal obesity, impaired insulin response to glucose and hyperlipidaemia. Female monkeys exposed to androgen excess late in gestation mimic these programmed changes, except for LH and insulin secretion defects. In utero androgen excess may thus variably perturb multiple organ system programming and thereby provide a single, fetal origin for a heterogeneous adult syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fetal, neonatal, prepubertal, and/or pubertal ovaries may be genetically predisposed to increased androgen secretion [100, 101].”
From Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls (2019) · cites this paper as [101]
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Sinclair, A. H., Berta, P., Palmer, M. S., Hawkins, J. R., Griffiths, B. L., Smith, M. J., Foster, J. W., Frischauf, A., Lovell-Badge, R. H., & Goodfellow, P. N. (1990) · Nature · doi:10.1038/346240a0 · Cited by 3,234
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,776
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311604 · Cited by 2,471
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Androgen Receptor Defects: Historical, Clinical, and Molecular Perspectives*
Quigley, C. A., Bellis, A. D., Marschke, K. B., Awady, M. K. E., Wilson, E. M., & French, F. S. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-271 · Cited by 1,459
Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., & Qin, K. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530621 · Cited by 1,416
Flagged first, then by citations
5 of the 231 references couldn’t be matched to a known paper.
Research works printed but not linked: 8
- Dewailly D, Cortet-Rudelli C and Deroubaix-Allard D (1997) Definition, clinical manifestations, and prevalence of PCOS. In Azziz R, Nestler JE, and Dewailly D (eds) Androgen Excess Disorders in Women. Lippincott-Raven Publishers, Philadelphia, PA, pp 259–268.
- Fischer DA (2003) Endocrinology of fetal development. In Larsen PR, Kronenberg HM, Melmed S, and Polonsky KS (eds) Williams Textbook of Endocrinology. 10th edn. WB Saunders, Philadelphia, PA, pp 811–841.
- Goy RW and Kemnitz JW (1983) Early, persistent, and delayed effects of virilizing substances delivered transplacentally to female rhesus fetuses. In Zbinden G, Cuomo V, Racagni G, and Weiss B (eds) Application of Behavioral Pharmacology in Toxicology. Raven Press, New York, pp 303–314.
- Goy RW, Uno H and Sholl SA (1988) Psychological and anatomical consequences of prenatal exposure to androgens in female rhesus. In Mori T and Nagasawa H (eds) Toxicity of Hormones in Perinatal Life. CRC Press, Inc., Boca Raton, Florida, pp 127–142.
- Hoar RM and Monie IW (1981) Comparative development of specific organ systems. In Kimmel CA and Buelke-Sam J (eds) Developmental Toxicology. Raven Press, New York, pp 13–33.
- Knobil E and Hotchkiss J (1994) The menstrual cycle and its neuroendocrine control. In Knobil E, Neill J, Ewing LL, Greenwald GS, Markert CL, and Pfaff DW (eds) The Physiology of Reproduction, Vol 2. Raven Press, New York, pp 1971–1994.
- Short RV (1974) Sexual differentiation of the brain of the sheep. In Forest MG and Bertrand J (eds) Sexual endocrinology of the perinatal period, Colloque International INSERM, Lyon. INSERM, Paris, France pp. 121–142.
- Sperling MA (1994) Carbohydrate metabolism: insulin and glucagons. In Tulchinsky D and Little AB (eds) Maternal–Fetal Endocrinology. 2nd edn. WB Saunders, Philadelphia, PA, pp 380–400.
Cited by
Sorted by citations
Items 101–200 of 554
Hart, R. J., Doherty, D. A., Frederiksen, H. W., Keelan, J. A., Hickey, M., Sloboda, D. M., Pennell, C. E., Newnham, J. P., Skakkebæk, N. E., & Main, K. M. (2013) · Reproduction · doi:10.1530/rep-13-0331 · Cited by 99
“In females, antenatal exposure of sheep and monkeys to androgens has been shown to cause a polycystic ovarian syndrome (PCOS)-like phenotype, although this as a potential cause of PCOS and is highly speculative (Abbott et al. 2005).”
BackgroundGestational Hyperandrogenism in Developmental Programming
Hakim, C. M., Padmanabhan, V., & Vyas, A. K. (2016) · Endocrinology · doi:10.1210/en.2016-1801 · Cited by 104
Polycystic ovary syndrome: Understanding the role of the brain
Moore, A. M., & Campbell, R. E. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.05.002 · Cited by 100
“signal within other androgen sensitive tissues like the brain (Table 1) (Abbott et al., 2005).”
BackgroundRole of androgens in the ovary
Walters, K. A., & Handelsman, D. J. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.06.026 · Cited by 98
Abbott, D. H., Bruns, C. M., Barnett, D. K., Dunaif, A. E., Goodfriend, T. L., Dumesic, D. A., & Tarantal, A. F. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00058.2010 · Cited by 97
“Such metabolic mechanisms underlying the ability of fetal androgen excess to induce PCOS-like metabolic phenotypes in female rhesus monkeys may explain differences in PCOS-like traits between various fetal androgen excess models (1, 33).”
BackgroundInfluentialPolycystic Ovary Syndrome in the Pediatric Population
Bremer, A. A. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0039 · Cited by 101
“In addition, intrauterine androgen exposure in these monkeys leads to the development of insulin resistance associated with visceral adiposity, impaired glucose metabolism, and dyslipidemia.(101) The above observations in both humans and monkeys thus support a potential role of epigenetics and fetal programming in the…”
Reproduction in females: The role of the early life environment
Sloboda, D. M., Hickey, M., & Hart, R. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq048 · Cited by 94
Thornton, J., Zehr, J. L., & Loose, M. D. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.03.015 · Cited by 105
Roland, A. V., & Moenter, S. M. (2010) · Endocrinology · doi:10.1210/en.2010-0823 · Cited by 95
Diamanti‐Kandarakis, E. (2009) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2009.09.005 · Cited by 92
Caldwell, A. S. L., Eid, S., Kay, C., Jimenez, M., McMahon, A. C., Desai, R., Allan, C. M., Smith, J. T., Handelsman, D. J., & Walters, K. A. (2015) · Endocrinology · doi:10.1210/en.2014-1887 · Cited by 90
“maturation, ovulatory disturbance, and miscarriage (2, 3),”
BackgroundInfluentialLinkage of regulators of TGF‐β activity in the fetal ovary to polycystic ovary syndrome
Hatzirodos, N., Bayne, R. A. L., Irving‐Rodgers, H. F., Hummitzsch, K., Sabatier, L., Lee, S. S., Bonner, W. M., Gibson, M. A., Rainey, W. E., Carr, B. R., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-181099 · Cited by 90
“nonhuman primates (6) produces an adult PCOS phe-”
BackgroundGenome-wide screen of ovary-specific DNA methylation in polycystic ovary syndrome
Yu, Y.-Y., Sun, C.-X., Liu, Y., Li, Y., Wang, L., & Zhang, W. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.04.005 · Cited by 91
Polycystic ovary syndrome in adolescents
Rothenberg, S. S., Beverley, R. M., Barnard, E., Baradaran-Shoraka, M., & Sanfilippo, J. S. (2017) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2017.08.008 · Cited by 88
Coyle, C., & Campbell, R. E. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110561 · Cited by 89
Effect of maternal PCOS and PCOS-like phenotype on the offspring's health
Puttabyatappa, M., Cardoso, R. C., & Padmanabhan, V. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.11.030 · Cited by 88
“Prenatally testosterone treated female rhesus monkeys have been shown to manifest hyperandrogenism and LH hypersecretion during the infantile development, suggesting that these may be endocrine antecedents of the adult PCOS-like phenotype (Abbott et al., 2005, Eisner et al., 2002).”
BackgroundNutritional adversity, sex and reproduction: 30 years of DOHaD and what have we learned?
Jazwiec, P. A., & Sloboda, D. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0048 · Cited by 73
Wu, Y., Zhong, G., Chen, S., Zheng, C., Liao, D., & Xie, M. (2017) · Human Reproduction · doi:10.1093/humrep/dex042 · Cited by 86
“In a remarkable series of experiments, Abbott et al. (2005) induced a phenotype distinctly resembling that of PCOS in prenatally androgenized female rhesus monkeys and found that the phenotype of PCOS differed according to the timing of the start of androgenization.”
BackgroundInfluentialLee, Y. H., Yang, H. J., Lee, S. R., Kwon, S. W., Hong, E., & Lee, H. W. (2018) · Nutrients · doi:10.3390/nu10101430 · Cited by 81
“As mentioned above, hyperandrogenism is a key factor in PCOS [7].”
BackgroundPusalkar, M., Meherji, P. K., Gokral, J., Chinnaraj, S., & Maitra, A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.07.016 · Cited by 81
Abbott, D. H., Zhou, R., Bird, I. M., Dumesic, D. A., & Conley, A. J. (2008) · KARGER eBooks · doi:10.1159/000134831 · Cited by 81
Zhou, R., Bird, I. M., Dumesic, D. A., & Abbott, D. H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0691 · Cited by 80
“As an established nonhuman primate model for PCOS (21,22,23), the prenatally androgenized (PA) female rhesus monkey provides an opportunity to examine whether exposure to androgen excess during fetal life provides a developmental origin for adrenal androgen excess in adulthood.”
BackgroundMa, Y., Andrisse, S., Chen, Y., Childress, S., Xue, P., Wang, Z., Jones, D., Ko, C. J., DiVall, S. A., & Wu, S. (2016) · Endocrinology · doi:10.1210/en.2016-1608 · Cited by 80
Berg, T., Silveira, M. A., & Moenter, S. M. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2304-17.2018 · Cited by 76
“Exposure to androgens during prenatal development produces neuroendocrine features similar to those of PCOS in adult animals, including rodents, sheep, and rhesus macaques (Birch et al., 2003; Sullivan and Moenter, 2004; Abbott et al., 2005; Foecking et al., 2005).”
BackgroundNohara, K., Waraich, R. S., Liu, S., Ferron, M., Waget, A., Meyers, M. S., Karsenty, G., Burcelin, R., & Mauvais-Jarvis, F. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00620.2012 · Cited by 77
“Furthermore, PCOS and MetS are believed to have a common developmental origin in which maternal androgen excess during pregnancy programs both the reproductive and metabolic abnormalities of the offspring (1, 51, 52).”
BackgroundThe serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
Chang, C. L., Huang, S. Y., Hsu, Y. C., Chin, T. H., & Soong, Y. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-42061-9 · Cited by 80
Letrozole: Pharmacology, toxicity and potential therapeutic effects
Mukherjee, A. G., Wanjari, U. R., Nagarajan, D., Vibhaa, K. K., Anagha, V., Joshua Paul, P., Thirumoorthy, T. P., Chakraborty, R., Renu, K., Dey, A., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121074 · Cited by 81
Padmanabhan, V., & Veiga‐Lopez, A. (2011) · Seminars in Reproductive Medicine · doi:10.1055/s-0031-1275519 · Cited by 75
“Hyperandrogenemia Studies conducted thus far document that prenatal T excess induces functional hyperandrogenism in monkeys manifested as enhanced responsiveness to human chorionic gonadotropin.(33,34) Prenatal T-treated sheep also manifest functional hyperandrogenism reflected as increased ovarian(47) and hypothalami…”
Impact of Exogenous Testosterone on Reproduction in Transgender Men
Moravek, M. B., Kinnear, H. M., George, J. S., Batchelor, J., Shikanov, A., Padmanabhan, V., & Randolph, J. F. (2020) · Endocrinology · doi:10.1210/endocr/bqaa014 · Cited by 77
Wang, P., Zhao, H., Li, T., Zhang, W., Wu, K., Li, M., Bian, Y., Liu, H., Ning, Y., Li, G., et al. (2014) · Endocrinology · doi:10.1210/en.2013-1764 · Cited by 75
“Evidence indicates that an excess of prenatal testosterone could program PCOS-like phenotypes in female mammals, including rhesus monkeys, sheep, mice, and rats, suggesting a role for the intrauterine environment in PCOS pathogenesis (18, 19).”
BackgroundPolycystic Ovary Syndrome: Do Endocrine-Disrupting Chemicals Play a Role?
Sobolewski, M., & Barrett, E. S. (2014) · Seminars in Reproductive Medicine · doi:10.1055/s-0034-1371088 · Cited by 81
Shpakov, A. O. (2021) · Pharmaceuticals · doi:10.3390/ph14010042 · Cited by 83
Solano, M. E., Sander, V. A., Ho, H., Motta, A. B., & Arck, P. (2011) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2011.09.003 · Cited by 74
“Over the past years, several animal models have been developed with the intent of studying the complexity of PCOS (reviewed by Abbott et al. (2005)).”
BackgroundThe ovarian dysgenesis syndrome
Louis, G. M. B., Cooney, M., & Peterson, C. M. (2011) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174410000693 · Cited by 73
“speculated that PCOS was a primary ovarian abnormality leading to androgen excess supporting early work in sheep and rhesus monkeys.(98) We are unaware of any human studies examining in utero chemical exposures in humans and later onset PCOS.”
BackgroundPractical Approach to Hyperandrogenism in Women
Sharma, A. R., & Welt, C. K. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.06.008 · Cited by 72
Abbott, A. D., Colman, R. J., Tiefenthaler, R., Dumesic, D. A., & Abbott, D. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042372 · Cited by 72
“Due to the mid-to-late reproductive years of the monkeys used [36,37], an independent observer scored all the phalanges for arthritis while blind to animal group.”
MethodNeuroendocrine consequences of androgen excess in female rodents
Foecking, E. M., McDevitt, M. A., Acosta‐Martínez, M., Horton, T. H., & Levine, J. E. (2008) · Hormones and Behavior · doi:10.1016/j.yhbeh.2007.12.013 · Cited by 73
“Evidence from both clinical and animal studies suggests that PCOS has a developmental origin, in which androgen excess during fetal or prepubertal life can reprogram multiple tissues to manifest the syndrome in adolescence and adulthood (Abbott et al., 2005; Xita and Tsatsoulis, 2006).”
BackgroundHormonal Programming Across the Lifespan
Nugent, B., Tobet, S., Lara, H., Lucion, A., Wilson, M., Recabarren, S., & Paredes, A. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0032-1312593 · Cited by 71
McGee, W., Bishop, C., Bahar, A., Pohl, C., Chang, R., Marshall, J., Pau, F., Stouffer, R., & Cameron, J. (2012) · Human Reproduction · doi:10.1093/humrep/der393 · Cited by 71
“Similarly, previous studies in female monkeys have shown that excess androgen exposure during fetal development can lead to later HA, irregular or absent menstrual cycles, elevated LH levels and polycystic ovaries as adults (Abbott et al., 1998, 2005, 2008).”
BackgroundKallak, T. K., Hellgren, C., Skalkidou, A., Sandelin-Francke, L., Ubhayasekhera, K., Bergquist, J., Axelsson, O., Comasco, E., Campbell, R. E., & Sundström Poromaa, I. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0207 · Cited by 70
Developmental programming of the female reproductive system—a review
Yao, S., López‐Tello, J., & Sferruzzi-Perri, A. N. (2020) · Biology of Reproduction · doi:10.1093/biolre/ioaa232 · Cited by 72
“Studies in sheep, rodents, and monkeys have also found that intrauterine exposure to excess testosterone leads to characteristic features of PCOS by adulthood [93, 152, 153].”
BackgroundInfluentialPriya, K., Setty, M. M., Babu, U. V., & Pai, K. S. R. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16489-4 · Cited by 78
What has sex got to do with it? The role of hormones in the transgender brain
Nguyen, H. B., Loughead, J., Lipner, E., Hantsoo, L. V., Kornfield, S. L., & Epperson, C. N. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0140-7 · Cited by 78
Piltonen, T., Giacobini, P., Edvinsson, Å., Hustad, S., Lager, S., Morin-Papunen, L. C., Tapanainen, J. S., Poromaa, I. S., & Arffman, R. K. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.11.028 · Cited by 68
Early origins of polycystic ovary syndrome
Dumesic, D. A., Schramm, R. D., & Abbott, D. H. (2005) · Reproduction Fertility and Development · doi:10.1071/rd04092 · Cited by 67
Introducing a rat model of prenatal androgen‐induced polycystic ovary syndrome in adulthood
Tehrani, F. R., Noroozzadeh, M., Zahediasl, S., Piryaei, A., & Azizi, F. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2014.078055 · Cited by 68
“In female monkeys exposed to androgen during fetal life (Steiner et al. 1976; Abbott et al. 2005; Dumesic et al. 2005) and in women with PCOS (Daniels & Berga, 1997; Eagleson et al. 2000), diminished negative feedback of sex steroids was reported, which may be explained by increased pulsatile LH…”
BackgroundFerk, P., Teran, N., & Geršak, K. (2006) · Human Reproduction · doi:10.1093/humrep/del457 · Cited by 67
“The (TAAAA)n SHBG polymorphism could be one of the factors representing a genetic link to the developmental origin hypothesis for PCOS ( Abbott et al., 2002, 2005; Dumesic et al., 2005), by which individuals with genetically determined low SHBG levels may be exposed to high free androgen levels during fetal life, prog…”
BackgroundLi, Q., Du, J., Feng, R., Xu, Y., Wang, H., Sang, Q., Xing, Q., Zhao, X., Li, J., He, L., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3685 · Cited by 66
“Intrinsic abnormality in the hypothalamic GnRH pulse generator (33), insulin resistance (2), lipotoxicity (34), fetal or perinatal androgen excess (35), and genetic factors (36) are all related to the etiology of the disease.”
BackgroundBaba, T., Endo, T., Ikeda, K., Shimizu, A., Honnma, H., Ikeda, H., Masumori, N., Ohmura, T., Kiya, T., Fujimoto, T., et al. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02252.x · Cited by 67
Li, Z., & Huang, H. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2006.09.076 · Cited by 66
Cernea, M., Padmanabhan, V., Goodman, R. L., Coolen, L. M., & Lehman, M. N. (2015) · Endocrinology · doi:10.1210/en.2014-1609 · Cited by 65
“Altered sensitivity to steroid feedback and reproductive abnormalities have also been shown in women with PCOS (10, 24) and in other animal models for this disease, including female rhesus monkeys (25), rats (26), and mice (24) exposed to prenatal T or dihydrotestosterone.”
BackgroundClustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys
Abbott, D. H., Rayome, B. H., Dumesic, D. A., Lewis, K. C., Edwards, A. K., Wallen, K., Wilson, M. E., Appt, S. E., & Levine, J. E. (2017) · Human Reproduction · doi:10.1093/humrep/dex036 · Cited by 66
Epigenetic Modification of the X Chromosome Influences Susceptibility to Polycystic Ovary Syndrome
Hickey, T. E., Legro, R. S., & Norman, R. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0069 · Cited by 67
“Same clinical presentation Unaffected-unaffected 2 2 (100) 0 PCOS-PCOS or HA-HA 11 9 (82) 2 (18) Total 13 11 (85) 2 (15) Different clinical presentation Unaffected-affected 18 3 (17) 15 (83) PCOS-HA 7 1 (14) 6 (86) Total 25 4 (16) 21 (84)”
BackgroundChang, C. L., Huang, S. Y., Soong, Y. K., Cheng, P. J., Wang, C., & Liang, I. T. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1180 · Cited by 68
REPRODUCTION SYMPOSIUM: Developmental programming of reproductive and metabolic health1,2
Padmanabhan, V., & Veiga‐Lopez, A. (2014) · Journal of Animal Science · doi:10.2527/jas.2014-7637 · Cited by 63
“Many believe PCOS may be a developmental disorder stemming from in utero exposure to excess androgens (Abbott et al., 2005).”
Polycystic ovarian syndrome – prognosis and outcomes
Hart, R. J., & Norman, R. J. (2006) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2006.04.006 · Cited by 63
Hogg, K., McNeilly, A. S., & Duncan, W. C. (2011) · Endocrinology · doi:10.1210/en.2010-1219 · Cited by 62
“Although this study did not examine the adult ovarian phenotype, prenatal androgen exposure at different time points is associated with changes in adult ovarian function (6, 46).”
BackgroundHuman Fetal Ovary Development Involves the Spatiotemporal Expression of P450c17 Protein
Cole, B., Hensinger, K., Maciel, G. A. R., Chang, R. J., & Erickson, G. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0641 · Cited by 61
Crisosto, N., Echiburú, B., Maliqueo, M. A., Pérez, V., de Guevara, A. L., Preisler, J., Sánchez, F., & Sir‐Petermann, T. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.10.002 · Cited by 62
Witham, E. A., Meadows, J. D., Shojaei, S., Kauffman, A. S., & Mellon, P. L. (2012) · Endocrinology · doi:10.1210/en.2012-1283 · Cited by 66
Fetal programming of polycystic ovary syndrome
Gür, E. B. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i7.936 · Cited by 62
Porter, D. T., Moore, A. M., Cobern, J. A., Padmanabhan, V., Goodman, R. L., Coolen, L. M., & Lehman, M. N. (2019) · Endocrinology · doi:10.1210/en.2019-00137 · Cited by 61
Nonhuman primates as models for human adrenal androgen production: Function and dysfunction
Abbott, D. H., & Bird, I. M. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9099-8 · Cited by 62
“In adulthood, such androgen excess exposed PA female monkeys exhibit irregular or absent ovulatory menstrual cycles, ovarian hyperandrogenism, enlarged polyfollicular ovaries and luteinizing hormone excess, as well as insulin resistance, increased incidence of type 2 diabetes, visceral adiposity and hyperlipidemia [1,…”
BackgroundManikkam, M., Thompson, R. C., Herkimer, C., Welch, K. B., Flak, J. N., Karsch, F. J., & Padmanabhan, V. (2007) · Biology of Reproduction · doi:10.1095/biolreprod.107.063347 · Cited by 61
“Hypersecretion of LH associated with reproductive abnormalities is also evident following prenatal exposure to excess testosterone in female rhesus monkeys [9], mice [10], and rats [11], and it is also seen in women with polycystic ovary syndrome [12, 13].”
BackgroundInfluentialPuberty and polycystic ovary syndrome
Witchel, S. F. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.04.028 · Cited by 61
“LH hypersecretion could reflect a primary intrinsic abnormality of the GnRH pulse generator perhaps related to prenatal programming (Abbott et al, 2005).”
BackgroundKeller, E., Chazenbalk, G. D., Aguilera, P., Madrigal, V., Grogan, T., Elashoff, D., Dumesic, D. A., & Abbott, D. H. (2014) · Endocrinology · doi:10.1210/en.2014-1050 · Cited by 60
Amalfi, S., Vélez, L. M., Heber, M. F., Vighi, S., Ferreira, S. R., Orozco, A. S. V., Pignataro, O. P., & Motta, A. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037658 · Cited by 58
“In the brain, a prenatal excess of testosterone induces sex differences [9] and defeminization by increasing pulses of gonadotropin-releasing hormone (GnRH) [13].”
BackgroundDaan, N. M. P., Koster, M. P. H., Steegers‐Theunissen, R. P. M., Eijkemans, M. J. C., & Fauser, B. C. J. M. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.042 · Cited by 59
“Intrauterine conditions may potentially contribute to the development of PCOS and associated complications in the later life of exposed offspring (11).”
BackgroundInfluentialRomero‐Ruíz, A., Skorupskaite, K., Gaytán, F., Torres, E., Perdices-López, C., Mannaerts, B. M. J. L., Qi, S., León, S., Manfredi-Lozano, M., Lopez-Rodriguez, C., et al. (2019) · Human Reproduction · doi:10.1093/humrep/dez205 · Cited by 59
Inappropriate gonadotropin secretion in polycystic ovary syndrome
Hsu, M.-I., Liou, T., Liang, S.-J., Su, H.-W., Wu, C., & Hsu, C.-S. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.01.036 · Cited by 58
“Second, the PCOS risk factor–positive (PCOSrf) group included 74 women who had one and only one of three PCOS components: [1] PCOM only; [2] oligomenorrhea or amenorrhea, or anovulation (Oligo-An) only; [3] and hyperandrogenism and/or hyperandrogenemia (HA) only.”
BackgroundMethodInfluentialXita, N. V., Georgiou, I. A., Lazaros, L. A., Psofaki, V., Kolios, G. C., & Tsatsoulis, A. A. (2008) · Human Reproduction · doi:10.1093/humrep/dem382 · Cited by 58
“In addition, increasing evidence based on experimental animal research supports the developmental origin hypothesis of PCOS, whereby fetal exposure to androgen excess may programme in utero the development of PCOS in adult life (Abbott et al., 2002, 2005; Xita and Tsatsoulis, 2006).”
BackgroundLegro, R. S., Roller, R. L., Dodson, W. C., Stetter, C. M., Kunselman, A. R., & Dunaif, A. E. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1849 · Cited by 54
Crisosto, N., Sir‐Petermann, T., Greiner, M., Maliqueo, M. A., Moreno, M. A. C., Aedo, P., & Lara, H. E. (2009) · Endocrine · doi:10.1007/s12020-009-9227-6 · Cited by 55
“It has been hypothesized that the increased number of small follicles present in PCOS is due to the trophic effects of androgens, whether increased locally in the ovary, or systemically, as has been observed in prenatal androgenization experimental models [6, 7 ]. This increased follicular mass, through the secretion…”
Sex differences in the effects of androgens acting in the central nervous system on metabolism
Morford, J. J., & Mauvais‐Jarvis, F. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.4/fmauvais · Cited by 53
DNA methylation in polycystic ovary syndrome: Emerging evidence and challenges
Liu, Y., Qin, Y. M., Wu, B., Peng, H., Li, M., Luo, H., & Liu, L. L. (2022) · Reproductive Toxicology · doi:10.1016/j.reprotox.2022.04.010 · Cited by 58
Padmanabhan, V., Veiga‐Lopez, A., Herkimer, C., Salloum, B. A., Moeller, J., Beckett, E. M., & Sreedharan, R. (2015) · Endocrinology · doi:10.1210/en.2015-1235 · Cited by 54
Rae, M. T., Grace, C., Hogg, K., Wilson, L. M., McHaffie, S. L., Ramaswamy, S., MacCallum, J., Connolly, F., McNeilly, A. S., & Duncan, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056263 · Cited by 53
“metabolic aspects, is reminiscent of PCOS in women [4,6,9,10,19].”
BackgroundMethodOvarian and Adrenal Hyperandrogenism
Carmina, E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.011 · Cited by 53
Schüring, A. N., Welp, A., Gromoll, J., Zitzmann, M., Sonntag, B., Nieschlag, E., Greb, R. R., & Kiesel, L. (2011) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0031-1291343 · Cited by 53
Hormone-induced rat model of polycystic ovary syndrome: A systematic review
Noroozzadeh, M., Behboudi‐Gandevani, S., Zadeh–Vakili, A., & Tehrani, F. R. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.10.020 · Cited by 61
“It has been reported that the effect of androgen on the female reproductive system is highly influenced by the time of exposure [8, 39].”
BackgroundA tale of two steroids: The importance of the androgens DHEA and DHEAS for early neurodevelopment
Greaves, R. F., Wudy, S. A., Badoer, E., Zacharin, M., Hirst, J. J., Quinn, T., & Walker, D. W. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.12.007 · Cited by 54
Non-classic congenital adrenal hyperplasia
Witchel, S. F. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.010 · Cited by 52
Prenatal Exposure to Endocrine Disruptors: A Developmental Etiology for Polycystic Ovary Syndrome
Hewlett, M., Chow, E., Aschengrau, A., & Mahalingaiah, S. (2017) · Reproductive Sciences · doi:10.1177/1933719116654992 · Cited by 61
“Regardless of timing of exposure (early or late), prenatally exposed female rhesus monkeys had ovulatory dysfunction and decreases in menstrual cycle length by 40% to 50% compared to unexposed female monkeys.(17) Another study demonstrated that prenatal excess androgen exposure resulted in increased numbers of small-,…”
BackgroundReproductive neuroendocrine dysfunction in polycystic ovary syndrome: Insight from animal models
Roland, A. V., & Moenter, S. M. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.04.002 · Cited by 57
“3.1 Prenatal androgenization recapitulates PCOS phenotypes across species The ability of prenatal androgen to reproduce both reproductive and metabolic traits of PCOS has been demonstrated in rhesus monkeys, sheep, rats, and mice (reviewed in Abbott et al., 2005; Padmanabhan and Veiga-Lopez, 2013).”
BackgroundInfluentialThe neuroendocrine genesis of polycystic ovary syndrome: A role for arcuate nucleus GABA neurons
Moore, A. M., & Campbell, R. E. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.10.002 · Cited by 54
Homburg, R., Gudi, A., Shah, A. M., & Layton, A. (2017) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-017-0282-1 · Cited by 51
“Studies on pregnant monkeys injected with testosterone [2], prevalenceof tom-boy behaviour of female children [3] and even an increased incidence of autism spectrum disorders [4], have all corroborated the possible influence of hyper-exposure to testosterone in-utero.”
BackgroundBertoldo, M. J., Caldwell, A. S. L., Riepsamen, A. H., Lin, D., Gonzalez, M. B., Robker, R. L., Ledger, W. J., Gilchrist, R. B., Handelsman, D. J., & Walters, K. A. (2019) · Endocrinology · doi:10.1210/en.2018-00966 · Cited by 52
Tehrani, F. R., Noroozzadeh, M., Zahediasl, S., Piryaei, A., Hashemi, S., & Azizi, F. (2014) · Intern J Endocrinol Metab · doi:10.5812/ijem.16502 · Cited by 50
“Several studies have introduced animal models of PCOS to assess the effects of prenatal exposure of animals to androgen excess; for example in mice, rats, sheep and monkeys, prenatal androgenized animals showed many symptoms of PCOS after puberty such as hyperandrogenemia, increased LH secretion, polycystic ovary, oli…”
BackgroundResultInfluentialSudhakaran, G., Kesavan, D., Kandaswamy, K., Guru, A., & Arockiaraj, J. (2024) · Reproductive Toxicology · doi:10.1016/j.reprotox.2023.108531 · Cited by 53
Radavelli‐Bagatini, S., Blair, A. R., Proietto, J., Spritzer, P. M., & Andrikopoulos, S. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0022 · Cited by 49
“Perhaps, a better model is the prenatally androgenized rhesus monkey that displays hyperandrogenism, anovulation, polyfollicular and enlarged ovaries and metabolic disturbances including increased adiposity and insulin insensitivity (Abbott et al. 1998, 2005, 2008).”
BackgroundZhou, R., Bruns, C. M., Bird, I. M., Kemnitz, J. W., Goodfriend, T. L., Dumesic, D. A., & Abbott, D. H. (2007) · Reproductive Toxicology · doi:10.1016/j.reprotox.2006.12.009 · Cited by 48
Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism
Abruzzese, G. A., Heber, M. F., Ferreira, S. R., Vélez, L. M., Reynoso, R., Pignataro, O. P., & Motta, A. B. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0471 · Cited by 48
Maternal effects in mammals: Broadening our understanding of offspring programming
Edwards, P. D., Lavergne, S. G., McCaw, L. K., Wijenayake, S., Boonstra, R., McGowan, P. O., & Holmes, M. M. (2021) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2021.100924 · Cited by 49
Why are women with polycystic ovary syndrome obese?
Barber, T. M. (2022) · British Medical Bulletin · doi:10.1093/bmb/ldac007 · Cited by 48
Differential DNA methylation patterns of polycystic ovarian syndrome in whole blood of Chinese women
Li, S., Zhu, D., Duan, H., Ren, A., Glintborg, D., Andersen, M., Skov, V., Thomassen, M., Kruse, T. A., & Tan, Q. (2016) · Oncotarget · doi:10.18632/oncotarget.9327 · Cited by 47
Which origin for polycystic ovaries syndrome: Genetic, environmental or both?
Fénichel, P., Rougier, C., Hiéronimus, S., & Chevalier, N. (2017) · Annales d Endocrinologie · doi:10.1016/j.ando.2017.04.024 · Cited by 50
Davies, M. J., March, W. A., Willson, K. J., Giles, L. C., & Moore, V. (2012) · Human Reproduction · doi:10.1093/humrep/des027 · Cited by 46
“As PCOS is a heterogeneous collection of symptoms, different presentations or symptoms may have different underlying aetiologies (Davies and Norman, 2002; Abbott et al., 2005).”
Maidana, P. N. A., Fritzler, A., Mocarbel, Y., Lana, M. B. P., González, D., Rosales, M., de Chazal, F. G., Sternberg, K., Majek, E. L., Mallea-Gil, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40653-z · Cited by 45
Vanky, E., Hanem, L. G. E., & Abbott, D. H. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.03.015 · Cited by 44
Sudhakaran, G., Guru, A., Haridevamuthu, B., Murugan, R., Arshad, A., & Arockiaraj, J. (2022) · Life Sciences · doi:10.1016/j.lfs.2021.120276 · Cited by 47
Metadata
- Authors
- Abbott, D. H., Barnett, D. K., Bruns, C. M., & Dumesic, D. A.
- Corresponding author
- Abbott, D.H.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-07-01
- Volume
- 11
- Issue
- 4
- Pages
- 357-374
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2123009569
- Cited by
- 555
- References
- 231
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 24 · 2023: 27 · 2022: 27 · 2021: 21 · 2020: 27 · 2019: 37 · 2018: 23 · 2017: 30 · 2016: 34 · 2015: 28 · 2014: 32 · 2013: 31 · 2012: 23
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction Update (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5u01hd044650-05)
- National Institute on Aging (T32AG000268)
- National Center for Research Resources (R01RR013635, R21RR014093, P51RR000167)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD044405, U01-HD044650)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, hyperandrogenism, fetal programming, developmental origins of health and disease, rhesus monkeys, prenatal androgen exposure, ovulatory dysfunction, insulin resistance, hyperlipidemia
- MeSH terms
- Androgens, Animals, Female, Genitalia, Female, Humans, Polycystic Ovary Syndrome, Hyperandrogenism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review